RedHill to host investor day April 27

|By:, SA News Editor

RedHill Biopharma (NASDAQ:RDHL) will host an investor day on Thursday, April 27 from 8:00 am - 10:00 am in New York City. A live webcast will be available through its website.

Key upcoming events: top-line results from Phase 2 study of BEKINDA in gastroenteritis and gastritis this quarter and top-line data from a Phase 3 study of BEKINDA in IBS-D in Q3.